Drugs / Promestriene

Trials 2 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT01370798 May 2011 → Sep 2017 hypospadias Hospices Civils de Lyon Completed No outcome recorded
Phase 41 trial
Phase 4 NCT05863975 Jul 2023 → Dec 2025 human papilloma virus infection Qianfoshan Hospital Unknown No outcome recorded
Also used as a comparator or background therapy in 6 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT04232813 Comparator Jan → Jun 2020 postmenopausal atrophic vaginitis Instituto Palacios Completed No outcome recorded
Phase 42 trials
Phase 4 NCT07153276 Comparator Feb 2026 → Sep 2029 expected Sjogren syndrome University of Sao Paulo General Hospital Recruiting No outcome recorded
Phase 4 NCT03032848 Comparator Nov 2013 → Dec 2016 endometrial disorder, pelvic organ prolapse, postmenopausal atrophic vaginitis Federal University of Paraná Completed No outcome recorded
Phase not applicable3 trials
NCT04657536 Comparator Dec 2020 → Dec 2021 postmenopausal atrophic vaginitis Peking University People's Hospital Unknown No outcome recorded
NCT04081805 Comparator Sep 2019 → Sep 2025 overdue breast cancer, postmenopausal atrophic vaginitis Federal University of São Paulo Active not recruiting No outcome recorded
NCT04717245 Comparator Oct 2018 → Mar 2019 postmenopausal atrophic vaginitis University of Sao Paulo General Hospital Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as Promestriene “② Promestriene group: promestriene cream vaginal medication.” NCT05863975
7

NCT04717245

NCT01370798

NCT04232813

NCT04081805

NCT04657536

NCT03032848

NCT07153276

Known as Colpotrophine ChEMBL registry synonym — accepted as the source's own label CHEMBL2105394
Known as Promestrieno ChEMBL registry synonym — accepted as the source's own label CHEMBL2105394
Modality Other / unclassified “promestriene topical estrogen” PMID 38714422 Apr 2024
Route Topical “Promestriene cream 1%, 1g per day during 2 months, cutaneous application” NCT01370798